Document is current
Any future updates will be listed below
-
Authors
Lee, Min-Sik https://orcid.org/0000-0002-0563-8113
Dennis, Courtney
Naqvi, Insia
Dailey, Lucas https://orcid.org/0000-0003-3204-9565
Lorzadeh, Alireza
Ye, George https://orcid.org/0000-0003-1380-7121
Zaytouni, Tamara https://orcid.org/0000-0001-7411-8915
Adler, Ashley
Hitchcock, Daniel S.
Lin, Lin
Hoffman, Megan T. https://orcid.org/0000-0003-0907-9977
Bhuiyan, Aladdin M.
Barth, Jaimie L.
Machacek, Miranda E. https://orcid.org/0000-0003-1067-0561
Mino-Kenudson, Mari https://orcid.org/0000-0002-9092-2265
Dougan, Stephanie K. https://orcid.org/0000-0002-2263-363X
Jadhav, Unmesh
Clish, Clary B. https://orcid.org/0000-0001-8259-9245
Kalaany, Nada Y. https://orcid.org/0000-0001-7489-1035
- License Information
-
More Information
Article History
Received: 22 January 2022
Accepted: 24 February 2023
First Online: 29 March 2023
Competing interests
: S.K.D. received research funding unrelated to this project from Eli Lilly and Company, Novartis Pharmaceuticals, Genocea and Bristol-Myers Squibb and is a founder, science advisory board member and equity holder in Kojin. M.M.-K. has served as a compensated consultant for AstraZeneca, Bristol-Myers Squibb, Sanofi and Janssen Oncology and has received loyalties from Elsevier, all unrelated to the current work.
